NOS2 and neoplasm: The overexpression of the inducible NO synthase including INOS and NOS2 has been documented to predict poor survival outcome in multiple cancers, based on the its involvement in immunosuppression by altering the tumor microenvironment and resulting in the resistance to the inhibitor of immune-checkpoint genes (Ekmekcioglu et al., 2017).